Show
Sort by
-
Synthesis and assessment of [C-11]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography
-
Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies
-
Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies
-
Evaluation of cerebral neurotransmitter physiology and pathophysiology with PET and SPET imaging modalities in animal models
-
Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings
-
Biodistribution and displacement studies of the selective 5-HT2A receptor antagonist I-123-5-I-R91150 in the normal dog.